2018
DOI: 10.29252/jabr.05.04.05
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Evaluation of Antibacterial Properties of Zinc Oxide Nanoparticles on Pathogenic Prokaryotes

Abstract: Introduction: Recent increases in microbial resistance to multiple antibiotics have led to the emergence of more economical methods for producing nanoparticles with physical, chemical effects and limited resistance. The aim of this research was to study zinc oxide (ZnO) nanoparticles synthesis and antibacterial properties against some gram-negative and gram-positive bacteria. Material and Methods: In this study, ZnO nanoparticle was synthesized using ultrasonic method and bioassayed on 10 human pathogenic bact… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(15 citation statements)
references
References 21 publications
(22 reference statements)
0
15
0
Order By: Relevance
“…Ibrahem et al [ 55 ] also recounted the concentration-dependent manner of zinc oxide nanoparticles. Nazoori and Kariminik [ 56 ] investigated the antimicrobial efficiency of zinc oxide nanoparticles against ten (10) human pathogenic organisms, and reported that the minimum concentration of zinc oxide that can inhibit or prevent the growth of most of S. aureus , S. marcescens and E. coli cultures was 2.5mg/mL of synthesized ZnO-NPs, while the minimum concentration required to kill off the bacterial strains was 10mg/mL. In another study by Akbar et al [ 33 ], ZnO nanoparticles were synthesized and their antimicrobial potential against foodborne pathogens S. typhimurium and S. aureus was evaluated.…”
Section: Resultsmentioning
confidence: 99%
“…Ibrahem et al [ 55 ] also recounted the concentration-dependent manner of zinc oxide nanoparticles. Nazoori and Kariminik [ 56 ] investigated the antimicrobial efficiency of zinc oxide nanoparticles against ten (10) human pathogenic organisms, and reported that the minimum concentration of zinc oxide that can inhibit or prevent the growth of most of S. aureus , S. marcescens and E. coli cultures was 2.5mg/mL of synthesized ZnO-NPs, while the minimum concentration required to kill off the bacterial strains was 10mg/mL. In another study by Akbar et al [ 33 ], ZnO nanoparticles were synthesized and their antimicrobial potential against foodborne pathogens S. typhimurium and S. aureus was evaluated.…”
Section: Resultsmentioning
confidence: 99%
“…However, authors claim that the price of zinc oxide is an encouraging factor in applying it in anti-microbial products. Iranian researchers [ 68 ] have documented the anti-microbial activity of zinc oxide nanoparticles against ten human pathogens, including Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Serratia marcescens, Salmonella typhi, Acinetobacter baumannii, Citrobacter freundii, Proteus mirabilis, Staphylococcus aureus and Bacillus cereus . The bioassay was based on the agar well diffusion method.…”
Section: Resultsmentioning
confidence: 99%
“…Measurement of the minimum inhibitory concentration of vancomycin and zinc nanoparticles MIC results of the current study contradicted the results of several studies, including the study of the researcher Karim (2015), where the MIC values were (2500-325) μg/mL for ZnO 20 and ZnO 150-50 and nm 30 and the MIC values were between (2600-126.5) μg/mL Whereas in Abdulrahman and Nssaif (2016) the MIC values for ZnO 20 were (256) μg/mL, the MIC for ZnO 30 was (341) μg/mL and ZnO 150-50 was (160) μg/mL. MIC results in the study of Nazoori and Kariminik (2018) were ZnO (2500 -5000) μg /mL but for other bacterial species. In the study of Aleaghil et al (2016), the MIC values of ZnO ranged between (5000-625) μg/mL, which was close to the results of the current study.…”
Section: A Antibiotic Sensitivity Testmentioning
confidence: 90%